SCHEMBL7974061

SCHEMBL7974061

Cc1ccc(Cn2cnc3[nH]c(-c4ccccc4F)nc(=O)c32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 2/20 0.42
PARN O95453 1/20 0.42
THRB P10828 1/20 0.42
ACP1 P24666 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
HTT P42858 2/20 0.40
LMNA P02545 2/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
CXCR2 P25025 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HPGD P15428 3/20 0.39
P2RX7 Q99572 3/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 2/20 0.36
NPC1 O15118 1/20 0.36
S1PR2 O95136 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988188 0.91 CNOT7 (0.44) CNOT7PARNACP1SMN1; SMN2HTT
SCHEMBL7974647 0.91 CNOT7 (0.51) CNOT7PARNACP1SMN1; SMN2HTT
SCHEMBL7974312 0.89 HPGD (0.45) CNOT7PARNACP1SMN1; SMN2HTT
SCHEMBL7984201 0.89 ABCC8 (0.44) CNOT7PARNACP1SMN1; SMN2CXCR2
SCHEMBL7984880 0.85 P2RX7 (0.46) CNOT7PARNACP1SMN1; SMN2HTT
SCHEMBL7984720 0.84 CNOT7 (0.48) CNOT7PARNACP1SMN1; SMN2HTT
SCHEMBL7973921 0.84 ALDH1A1 (0.42) CNOT7PARNACP1LMNAP2RX7
SCHEMBL7988457 0.84 PARN (0.42) CNOT7PARNACP1SMN1; SMN2CXCR2
SCHEMBL7974056 0.83 HPGD (0.47) THRBACP1SMN1; SMN2HTTLMNA
SCHEMBL7985168 0.83 KMT2A (0.46) CNOT7PARNACP1CYP11B2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed